| Authors | E Ost, H J Illiger |
| Journal | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
(Strahlenther Onkol)
Vol. 178
Issue 1
Pg. 54-5
(Jan 2002)
ISSN: 0179-7158 [Print] Germany |
| Vernacular Title | Vergleich von Epirubicin und Cyclophosphamid in zwei Dosisstufen zum klassischen CMF-Protokoll bei nodal positiven Mammakarzinomen. Eine adjuvante Phase-III-Studie. |
| PMID | 11977396
(Publication Type: Comparative Study, Journal Article)
|
| Chemical References |
- Antibiotics, Antineoplastic
- Antimetabolites, Antineoplastic
- Antineoplastic Agents, Alkylating
- Antineoplastic Agents, Hormonal
- Tamoxifen
- Epirubicin
- Cyclophosphamide
- Cisplatin
- Fluorouracil
- Methotrexate
|
| Topics |
- Administration, Oral
- Antibiotics, Antineoplastic
(administration & dosage)
- Antimetabolites, Antineoplastic
(administration & dosage)
- Antineoplastic Agents, Alkylating
(administration & dosage)
- Antineoplastic Agents, Hormonal
(administration & dosage)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Breast Neoplasms
(drug therapy)
- Cisplatin
(therapeutic use)
- Clinical Trials, Phase III as Topic
- Cyclophosphamide
(administration & dosage)
- Epirubicin
(administration & dosage)
- Female
- Fluorouracil
(administration & dosage, therapeutic use)
- Follow-Up Studies
- Humans
- Lymphatic Metastasis
- Meta-Analysis as Topic
- Methotrexate
(administration & dosage, therapeutic use)
- Randomized Controlled Trials as Topic
- Tamoxifen
(administration & dosage)
- Time Factors
|
